Device Trial Radar · NCT02448342
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Last checked: Nov 21, 2026Latest source record: Dec 29, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
380
Planned (sponsor's estimate)
Start
Sep 2015
Primary completion
Nov 30, 2017
Study completion Nov 30, 2017
Sponsor
- Lead sponsor
- Sensible Medical Innovations Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 19, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multi center, randomized controlled study, to determine if a significant decrease in the rate of heart failure re-hospitalizations occurs during a follow-up period when - ReDS guided treatment is used as an adjunct to standard of care.
Conditions
- Heart Failure
Interventions
Remote Dielectric Sensing (ReDS) Wearable SystemDevice
The ReDS device provides noninvasive measurement of lung fluid content. It comprises a wearable vest with embedded sensors and a bedside console, with touch-screen display. A measurement reading is provided within 90sec. Results are shared with the treating physician via a secured web portal.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The rate of recurrent events of HF readmissionsTime frame: Entire follow-up period (Expected average of 6.5 months)
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
40 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.